Donald A. Bergstrom, President, R&D at Relay Therapeutics, Inc. (RLAY), sold 8,530 shares at $18.97 ($162K) on 2026-09-08, disclosed to the SEC on 2026-09-09.
Scheduled sale ($162k) by President, R&D under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RLAY | SELL | 2026-06-24 | $1.6M | — | Filing → |
| RLAY | SELL | 2026-04-30 | $22K | — | Filing → |
| RLAY | SELL | 2026-01-29 | $167K | — | Filing → |